Pacific Marine Biotech Australia

Pacific Marine Biotech was an Australian biotechnology company established to commercialize marine-derived bioactive compounds discovered by the Australian Institute of Marine Science (AIMS). Based in Townsville, the company focused on identifying and developing small molecule therapeutics from marine organisms, particularly sponges, for applications in oncology and inflammatory diseases. Its lead research programs centered on novel chemical scaffolds with potent anti-inflammatory properties, such as the PMB-01 compound. The company represented a significant effort to translate Australia's marine biodiversity into a pharmaceutical pipeline through collaborations with partners like AMRAD. Despite its early research successes, the company is no longer active and has been deregistered.